Of the group studied, 34 samples of colorectal adenocarcinoma (25.19%) had high levels of Grx1 protein expression, while 101 samples (74.81%) had low levels of Grx1 protein expression (Figure 1). The gene discussed is GLRX; the disease is colorectal adenocarcinoma.